Polymers and Nanoparticles for Statin Delivery: Current Use and Future Perspectives in Cardiovascular Disease
Atherosclerosis-related coronary artery disease (CAD) is one of the leading sources of mortality and morbidity in the world. Primary and secondary prevention appear crucial to reduce CAD-related complications. In this scenario, statin treatment was shown to be clinically effective in the reduction o...
Main Authors: | Antonio Nenna, Francesco Nappi, Domenico Larobina, Emanuele Verghi, Massimo Chello, Luigi Ambrosio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/13/5/711 |
Similar Items
-
The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy
by: Francesco Nappi, et al.
Published: (2021-01-01) -
Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy
by: Nunzio Montelione, et al.
Published: (2023-03-01) -
RELEVANCY OF HIGH DOSE STATINS APPLICATION BEFORE AND AFTER MYOCARDIUM REVASCULARIZATION
by: M. V. EZHOV
Published: (2016-12-01) -
Statins and stent thrombosis
by: Vincent Braunersreuther, et al.
Published: (2012-02-01) -
HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)